National Institute of Health
-
New Study at Willow Grove Naval Air Station Joint Reserve Base Looks At Potential ‘Forever Chemicals’ and Disease Link
In 2011, the U.S. Department of Defense and the Environmental Protection Agency confirmed toxic chemicals were in the Naval Air Station Joint Reserve Base Willow…
-
Lumberville Pharmaceutical Company Lands Multimillion-Dollar Grant
Lumberville-based Advent Therapeutics has landed a $3 million grant from the National Institute of Health to advance its treatment for preventing a rare lung disease…
-
Kannalife Sciences, Doylestown BioPharma Firm, Receives NIH Grant to Fund Pain Research
Kannalife Sciences, a subsidiary of Neuropathix, Inc., was awarded a $2.97 million grant from the National Institutes of Health’s National Institute of Neurological Disorders and…
-
Doylestown’s Neuropathix, Inc., Gains 20-Year Industry Veteran in Its Fight Against Opioid and Pain Addiction
Neuropathix, Inc., a pain management life sciences company in Doylestown, has appointed pharmaceutical industry veteran Michael Ropacki, PhD, to its scientific advisory board. Ropacki is…
Founding Partners
Advertisement
Affiliate Partners
